Lucerne Cantonal Hospital
Lucerne, Canton of Lucerne, 6000, Switzerland
Location status: Recruiting
Location contact
Sabrina Bäbler, MD
CONTACT
sabrina.bä[email protected]
Severin Rüssli, MD
CONTACT
Severin Rüssli, MD
SUB_INVESTIGATOR
NCT Number: NCT06869746
The Swiss Spinal Tumor Registry is a prospective REDCap-based registry, collecting data of surgically treated patients with primary and metastatic tumors of the spine.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Lucerne, Canton of Lucerne, 6000, Switzerland
Location status: Recruiting
Sabrina Bäbler, MD
CONTACT
sabrina.bä[email protected]
Severin Rüssli, MD
CONTACT
Severin Rüssli, MD
SUB_INVESTIGATOR
Tumors of the vertebral column consist of primary spinal tumors and malignancies metastasizing to the spine. While primary spine tumors represent a rare condition, metastases to the spine have gradually increased over past decades because of increases in aging population and continued advances in cancer therapy with improved survival times across multiple cancer subtypes. Metastases to the vertebral column are found in up to 70% of cancer patients, with 10% of patients demonstrating epidural spinal cord compression. Therefore, many cancer patients may face spinal surgical intervention at some point of their chronic illness. Numerous surgical treatment options are currently available, ranging from simple cement augmentation over decompression of neural elements to extended instrumentation or reconstruction of the spine, including hybrid procedures that combine these techniques. However, precise surgical treatment guidelines do not exist, likely due to the absence of robust, long-term clinical outcomes data in these patients, and the overall heterogeneous nature of spinal tumors. The primary goal of Swiss-STR is to inform on the effectiveness of current practice in spinal oncology and its impact on patient outcomes. Furthermore, it will help to better categorize the different clinical presentations of spinal tumors, thereby facilitating treatment recommendations, assessing the socio-economic burden of this condition to the healthcare system, and improving the quality of care. In cases of rare tumors, multicenter data pooling will fill significant data gaps, allowing a better understanding of these entities. Finally, the approach is to first build and implement a high-quality registry with efficient electronic data capture strategies across hospital sites in Switzerland, with the potential to later expand internationally, providing opportunities for future international scientific collaboration to push the envelope in cancer research further.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Through study completion, an average of 1 year
Rating in 10% steps
Time frame: Through study completion, an average of 1 year
Timed-Up-and-Go-Test in seconds
Contact information is provided by the study sponsor or research team.
Edin Nevzati, MD
CONTACT
Severin Rüssli, MD
CONTACT
Luzerner Kantonsspital
Other
Acronym: SSTR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07615491
Back Injuries, Bone Diseases
Izmir, Turkey (Türkiye)
View Trial DetailsNCT07429422
Bone Metastases, Central Nervous System Diseases
Ljubljana, Slovenia
View Trial DetailsNCT07224451
Central Nervous System Diseases, Central Nervous System Neoplasms
Ramat Gan, Israel
View Trial DetailsNCT02013297
Brain Diseases, Brain Metastasis
Nice, Alpes Maritimes, France
View Trial Details